AKT1 and cancer: Moreover, to reduce the ability of inhibiting autophagy, promoting proliferation and EMT by FGF2, and to inhibit the ability of promoting cancer cell metastasis by WNT7A, AKT1 was selected as a biomarker to be inhibited.